1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea

C103H100Cl4F4N24O17S8 — CID 159292178

IUPAC1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea
SMILESCc1nc2cc(C3=NCCN3C)ccc2c(=O)n1-c1ccc(NC(=O)NS(=O)(=O)c2ccc(Cl)s2)cc1F.Cc1nc2cc(NCCN3CCCC3)ccc2c(=O)n1-c1ccc(NC(=O)NS(=O)(=O)c2ccc(Cl)s2)cc1F.Cc1nc2cc(NCCN3CCCCC3)ccc2c(=O)n1-c1ccc(NC(=O)NS(=O)(=O)c2ccc(Cl)s2)cc1F.Cc1nc2cc(NCCN3CCOCC3)ccc2c(=O)n1-c1ccc(NC(=O)NS(=O)(=O)c2ccc(Cl)s2)cc1F
InChIInChI=1S/C27H28ClFN6O4S2.C26H26ClFN6O5S2.C26H26ClFN6O4S2.C24H20ClFN6O4S2/c1-17-31-22-16-18(30-11-14-34-12-3-2-4-13-34)5-7-20(22)26(36)35(17)23-8-6-19(15-21(23)29)32-27(37)33-41(38,39)25-10-9-24(28)40-25;1-16-30-21-15-17(29-8-9-33-10-12-39-13-11-33)2-4-19(21)25(35)34(16)22-5-3-18(14-20(22)28)31-26(36)32-41(37,38)24-7-6-23(27)40-24;1-16-30-21-15-17(29-10-13-33-11-2-3-12-33)4-6-19(21)25(35)34(16)22-7-5-18(14-20(22)28)31-26(36)32-40(37,38)24-9-8-23(27)39-24;1-13-28-18-11-14(22-27-9-10-31(22)2)3-5-16(18)23(33)32(13)19-6-4-15(12-17(19)26)29-24(34)30-38(35,36)21-8-7-20(25)37-21/h5-10,15-16,30H,2-4,11-14H2,1H3,(H2,32,33,37);2-7,14-15,29H,8-13H2,1H3,(H2,31,32,36);4-9,14-15,29H,2-3,10-13H2,1H3,(H2,31,32,36);3-8,11-12H,9-10H2,1-2H3,(H2,29,30,34)
InChIKeyLAGNKFNYQPOHRW-UHFFFAOYSA-N
MW2420.42 g/mol
LogP17.08
Rot. Bonds29

About 1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea

1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea (PubChem CID 159292178) has the molecular formula C103H100Cl4F4N24O17S8 and a molecular weight of 2420.42 g/mol. Its IUPAC name is 1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea.

Molecular Properties

Compound Name1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea
PubChem CID159292178
Molecular FormulaC103H100Cl4F4N24O17S8
Molecular Weight2420.42 g/mol
Exact Mass2416.42
IUPAC Name1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea
SMILESCc1nc2cc(C3=NCCN3C)ccc2c(=O)n1-c1ccc(NC(=O)NS(=O)(=O)c2ccc(Cl)s2)cc1F.Cc1nc2cc(NCCN3CCCC3)ccc2c(=O)n1-c1ccc(NC(=O)NS(=O)(=O)c2ccc(Cl)s2)cc1F.Cc1nc2cc(NCCN3CCCCC3)ccc2c(=O)n1-c1ccc(NC(=O)NS(=O)(=O)c2ccc(Cl)s2)cc1F.Cc1nc2cc(NCCN3CCOCC3)ccc2c(=O)n1-c1ccc(NC(=O)NS(=O)(=O)c2ccc(Cl)s2)cc1F
InChIInChI=1S/C27H28ClFN6O4S2.C26H26ClFN6O5S2.C26H26ClFN6O4S2.C24H20ClFN6O4S2/c1-17-31-22-16-18(30-11-14-34-12-3-2-4-13-34)5-7-20(22)26(36)35(17)23-8-6-19(15-21(23)29)32-27(37)33-41(38,39)25-10-9-24(28)40-25;1-16-30-21-15-17(29-8-9-33-10-12-39-13-11-33)2-4-19(21)25(35)34(16)22-5-3-18(14-20(22)28)31-26(36)32-41(37,38)24-7-6-23(27)40-24;1-16-30-21-15-17(29-10-13-33-11-2-3-12-33)4-6-19(21)25(35)34(16)22-7-5-18(14-20(22)28)31-26(36)32-40(37,38)24-9-8-23(27)39-24;1-13-28-18-11-14(22-27-9-10-31(22)2)3-5-16(18)23(33)32(13)19-6-4-15(12-17(19)26)29-24(34)30-38(35,36)21-8-7-20(25)37-21/h5-10,15-16,30H,2-4,11-14H2,1H3,(H2,32,33,37);2-7,14-15,29H,8-13H2,1H3,(H2,31,32,36);4-9,14-15,29H,2-3,10-13H2,1H3,(H2,31,32,36);3-8,11-12H,9-10H2,1-2H3,(H2,29,30,34)
InChIKeyLAGNKFNYQPOHRW-UHFFFAOYSA-N
XLogP17.08
TPSA511.28 Ų
H-Bond Donors11
H-Bond Acceptors37
Rotatable Bonds29
Heavy Atoms160
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002420.42
LogP ≤ 517.08
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1037

Analyze 1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea?
The IUPAC name of 1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea (CID 159292178) is 1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea.
What is the SMILES notation for 1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea?
The canonical SMILES for 1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea is Cc1nc2cc(C3=NCCN3C)ccc2c(=O)n1-c1ccc(NC(=O)NS(=O)(=O)c2ccc(Cl)s2)cc1F.Cc1nc2cc(NCCN3CCCC3)ccc2c(=O)n1-c1ccc(NC(=O)NS(=O)(=O)c2ccc(Cl)s2)cc1F.Cc1nc2cc(NCCN3CCCCC3)ccc2c(=O)n1-c1ccc(NC(=O)NS(=O)(=O)c2ccc(Cl)s2)cc1F.Cc1nc2cc(NCCN3CCOCC3)ccc2c(=O)n1-c1ccc(NC(=O)NS(=O)(=O)c2ccc(Cl)s2)cc1F.
What is the InChIKey of 1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea?
The InChIKey is LAGNKFNYQPOHRW-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H28ClFN6O4S2.C26H26ClFN6O5S2.C26H26ClFN6O4S2.C24H20ClFN6O4S2/c1-17-31-22-16-18(30-11-14-34-12-3-2-4-13-34)5-7-20(22)26(36)35(17)23-8-6-19(15-21(23)29)32-27(37)33-41(38,39)25-10-9-24(28)40-25;1-16-30-21-15-17(29-8-9-33-10-12-39-13-11-33)2-4-19(21)25(35)34(16)22-5-3-18(14-20(22)28)31-26(36)32-41(37,38)24-7-6-23(27)40-24;1-16-30-21-15-17(29-10-13-33-11-2-3-12-33)4-6-19(21)25(35)34(16)22-7-5-18(14-20(22)28)31-26(36)32-40(37,38)24-9-8-23(27)39-24;1-13-28-18-11-14(22-27-9-10-31(22)2)3-5-16(18)23(33)32(13)19-6-4-15(12-17(19)26)29-24(34)30-38(35,36)21-8-7-20(25)37-21/h5-10,15-16,30H,2-4,11-14H2,1H3,(H2,32,33,37);2-7,14-15,29H,8-13H2,1H3,(H2,31,32,36);4-9,14-15,29H,2-3,10-13H2,1H3,(H2,31,32,36);3-8,11-12H,9-10H2,1-2H3,(H2,29,30,34).
What are the key properties of 1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea?
1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea has a molecular weight of 2420.42 g/mol, XLogP of 17.08, 29 rotatable bonds, 11 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(1-methyl-4,5-dihydroimidazol-2-yl)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-7-(2-morpholin-4-ylethylamino)-4-oxoquinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-piperidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea;1-(5-chlorothiophen-2-yl)sulfonyl-3-[3-fluoro-4-[2-methyl-4-oxo-7-(2-pyrrolidin-1-ylethylamino)quinazolin-3-yl]phenyl]urea is sourced from PubChem (CID 159292178), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).